DOJ awards $3.36M for 2026-2027 flu vaccines to Sanofi Pasteur via full and open competition
Contract Overview
Contract Amount: $3,362 ($3.4K)
Contractor: Sanofi Vaccines US Inc.
Awarding Agency: Department of Justice
Start Date: 2026-09-30
End Date: 2026-09-30
Competition Type: FULL AND OPEN COMPETITION
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: INFLUENZA VIRUS VACCINES FOR THE FCI MILAN INMATES FOR THE 2026-2027 SEASON UNDER NATIONAL CONTRACT AWARD: SANOFI PASTEUR.
Place of Performance
Location: SWIFTWATER, MONROE County, PENNSYLVANIA, 18370
Plain-Language Summary
Department of Justice obligated $3,362.4 to SANOFI VACCINES US INC. for work described as: INFLUENZA VIRUS VACCINES FOR THE FCI MILAN INMATES FOR THE 2026-2027 SEASON UNDER NATIONAL CONTRACT AWARD: SANOFI PASTEUR. Key points: 1. The contract addresses a critical public health need for inmate vaccination. 2. Sanofi Pasteur is a major player in the vaccine market, indicating established competition. 3. The firm fixed price contract mitigates cost escalation risks. 4. Spending falls within the pharmaceutical preparation manufacturing sector.
Value Assessment
Rating: good
The award amount of $3.36M for flu vaccines appears reasonable given the scale of inmate populations and the typical cost of vaccines. Benchmarking against similar federal contracts for mass vaccination programs would provide further validation.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded under full and open competition, suggesting a robust price discovery process. This method typically leads to more competitive pricing compared to sole-source or limited solicitations.
Taxpayer Impact: The use of a national contract and competitive bidding aims to ensure taxpayer funds are used efficiently for essential healthcare services.
Public Impact
Ensures health and safety of inmates at FCI Milan. Supports public health by preventing disease outbreaks in a congregate setting. Provides a reliable supply of influenza vaccines for a vulnerable population.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Potential for supply chain disruptions impacting vaccine availability.
- Need to monitor vaccine efficacy against circulating strains.
Positive Signals
- Proactive planning for seasonal health needs.
- Utilizes a competitive procurement process.
- Firm fixed price contract locks in costs.
Sector Analysis
This contract falls under Pharmaceutical Preparation Manufacturing, a sector critical for public health and national security. Federal spending in this area often involves large-scale procurements for essential medicines and vaccines.
Small Business Impact
The data does not indicate any specific provisions or awards made to small businesses in this contract. Further analysis would be needed to determine if small businesses had an opportunity to participate.
Oversight & Accountability
The Department of Justice, through the Federal Prison System, is responsible for this procurement. Oversight would involve ensuring timely delivery, quality of vaccines, and adherence to contract terms.
Related Government Programs
- Pharmaceutical Preparation Manufacturing
- Department of Justice Contracting
- Federal Prison System / Bureau of Prisons Programs
Risk Flags
- Potential for supply chain disruptions.
- Reliance on a single manufacturer.
- Need for ongoing monitoring of vaccine effectiveness.
- Potential for price fluctuations in future seasons.
Tags
pharmaceutical-preparation-manufacturing, department-of-justice, pa, delivery-order, under-100k
Frequently Asked Questions
What is this federal contract paying for?
Department of Justice awarded $3,362.4 to SANOFI VACCINES US INC.. INFLUENZA VIRUS VACCINES FOR THE FCI MILAN INMATES FOR THE 2026-2027 SEASON UNDER NATIONAL CONTRACT AWARD: SANOFI PASTEUR.
Who is the contractor on this award?
The obligated recipient is SANOFI VACCINES US INC..
Which agency awarded this contract?
Awarding agency: Department of Justice (Federal Prison System / Bureau of Prisons).
What is the total obligated amount?
The obligated amount is $3,362.4.
What is the period of performance?
Start: 2026-09-30. End: 2026-09-30.
What is the historical cost per dose for influenza vaccines under similar federal contracts?
Historical data on per-dose costs for federal influenza vaccine contracts can vary based on the specific vaccine type, manufacturer, quantity, and contract duration. Benchmarking against previous Bureau of Prisons or other agency contracts for similar seasons would provide a more accurate comparison. Without specific historical data, it's difficult to definitively assess if this award represents a cost savings or premium.
What are the risks associated with relying on a single supplier for a critical vaccine during a flu season?
Relying on a single supplier, even through competitive award, carries risks such as potential supply chain disruptions, manufacturing issues, or unforeseen demand surges. While Sanofi Pasteur is a reputable manufacturer, having contingency plans or exploring multi-award contracts for future seasons could mitigate risks related to sole-source dependency for critical medical supplies.
How effective are influenza vaccines in preventing illness and transmission within correctional facilities?
Influenza vaccines are generally effective in reducing the risk of infection, severity of illness, and transmission of the flu virus. In correctional facilities, where close proximity can facilitate rapid spread, vaccination programs are crucial for protecting inmate health and preventing outbreaks that can strain facility resources and pose risks to staff.
Industry Classification
NAICS: Manufacturing › Pharmaceutical and Medicine Manufacturing › Pharmaceutical Preparation Manufacturing
Product/Service Code: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Parent Company: Sanofi
Address: 1 DISCOVERY DR, SWIFTWATER, PA, 18370
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Foreign-Owned and U.S.-Incorporated Business, Manufacturer of Goods, Not Designated a Small Business, Special Designations
Financial Breakdown
Contract Ceiling: $3,362
Exercised Options: $3,362
Current Obligation: $3,362
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES
Cost or Pricing Data: NO
Parent Contract
Parent Award PIID: 36E79724D0006
IDV Type: IDC
Timeline
Start Date: 2026-09-30
Current End Date: 2026-09-30
Potential End Date: 2026-09-30 00:00:00
Last Modified: 2026-04-10
More Contracts from Sanofi Vaccines US Inc.
- 00hcvgbc-2009-68767 - Sanofi VFC Pediatric Vaccine Contract — $737.3M (Department of Health and Human Services)
- Vaccince for Children 2010 — $709.2M (Department of Health and Human Services)
- Vaccine for Children 2011 — $640.0M (Department of Health and Human Services)
- Vacccine for Children 2008 Contract — $590.5M (Department of Health and Human Services)
- VFC 2012 — $589.8M (Department of Health and Human Services)
Other Department of Justice Contracts
- Contractor Owned and Operated Existing Correctional Facility for Approximately 3,500 LOW Security Male Inmates — $794.5M (Cornell Companies, Inc.)
- Detention Services - SAN Diego — $776.9M (THE GEO Group, Inc.)
- CO: Telly Renfroe Award of NEW Task Order Base Year Initial Funding — $616.4M (AT&T Enterprises, LLC)
- TAS 151060 - Services for the Management and Operation of a Contractor-Owned, Contractor-Operated, Correctional Facility for 2,567 Beds in Adams County, Mississippi — $574.3M (Corecivic, Inc.)
- Provide Services for the Management and Operation of a Correctional Facility in Accordance With Rfp-Pcc-0014 — $568.9M (Cornell Companies, Inc.)